Experienced in Dehydration

Roma Chilengi

Plot # 34620, Off Alick Nkhata Road, 
Lusaka, ZM 
Experienced in Dehydration
Plot # 34620, Off Alick Nkhata Road, 
Lusaka, ZM 
OverviewLocationsClinical Research

Overview

Roma Chilengi practices in Lusaka, Zambia. Ms. Chilengi is rated as an Experienced expert by MediFind in the treatment of Dehydration. Her top areas of expertise are Cholera, Diarrhea, HIV/AIDS, and Shigellosis.

Her clinical research consists of co-authoring 162 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Dehydration.

Gender
Female

Locations

Plot # 34620, Off Alick Nkhata Road, Lusaka, 34681, Zambia
Other Locations
Alick Nkhata Road, Lusaka, 34620, Zambia
Plot 5032 Great North Rd, Lusaka, Zambia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An International, Multi-site, Bayesian Platform Adaptive, Randomized, Placebo-controlled Trial Assessing the Effectiveness of Candidate Agents in Mitigating COVID-19 Disease in Adults
An International, Multi-site, Bayesian Platform Adaptive, Randomized, Placebo-controlled Trial Assessing the Effectiveness of Candidate Agents in Mitigating COVID-19 Disease in Adults
Enrollment Status: Completed
Publish Date: March 26, 2024
Intervention Type: Drug
Study Drug: MMR II Vaccine
Study Phase: Phase 3
Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine
Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine
Enrollment Status: Completed
Publish Date: April 05, 2021
Intervention Type: Biological
Study Phase: Phase 4
An Open-label, Randomized, Controlled, Single Centre, Phase IIb Study to Assess the Immunogenicity, Reactogenicity and Safety of Three Live Oral Rotavirus Vaccines, ROTAVAC® , ROTAVAC 5CM and Rotarix® in Healthy Zambian Infants
An Open-label, Randomized, Controlled, Single Centre, Phase IIb Study to Assess the Immunogenicity, Reactogenicity and Safety of Three Live Oral Rotavirus Vaccines, ROTAVAC® , ROTAVAC 5CM and Rotarix® in Healthy Zambian Infants
Enrollment Status: Completed
Publish Date: December 19, 2020
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
An Observational Study to Evaluate Causes of Rotavirus Vaccine Failure in Zambian Children in the Context of Routine Immunization Services
An Observational Study to Evaluate Causes of Rotavirus Vaccine Failure in Zambian Children in the Context of Routine Immunization Services
Enrollment Status: Completed
Publish Date: August 23, 2018
View 3 Less Clinical Trials

162 Total Publications

PEPFAR Investments in National Public Health Institutes: HIV Control Through Strong Systems.
PEPFAR Investments in National Public Health Institutes: HIV Control Through Strong Systems.
Journal: The Journal of infectious diseases
Published: September 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Chilengi's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile